![]() |
|
|||||||||||||||||||
|
|
||||||||||||||||||||
|
|
||||||||||||||||||||
|
|
||||||||||||||||||||
|
| ||||||||||||||||||||
|
Advertise your job openings on this site for 1 month FREE
Make Adchat your one stop for the latest news in the pharmaceutical healthcare industry. Stop by often for updates on drug trials, drug approvals and much more. Then visit the message boards, to see what's happening in the pharmaceutical advertising agencies. Join now or post anonymously! Registration is free!
|
|
|||||||||||||||||||
|
|
ONCOLOGY
SHS Recruiters
Internet Drug News.com
pogofrog.com
HealthcareAdvertising
![]()
The Symbolism of Color
MediLexicon
Avenue A | Razorfish - has added
4A's: Industry Leaders Tout Innovation Merck shares fall on FDA drug rejection, Abbott shares rise Witty appoints Hussein for new markets FDA to hire 1,300 as criticism grows Interpublic to Settle With SEC MediaVest Wins Lucrative Pharma Account Wyeth and Amgen bolster fatal infection warning on skin drugMerck and Schering Plough - allergic to each other? Avastin study fails to show improved lung cancer survival Watson Files FDA Application for Generic YASMIN(R) An anti-seizure drug used to treat Reegan Schwartz’s epilepsy registered a fourteenfold increase in price last summer. Harvard Docs: Bring On the Drug Reps Incontinence Drugs May Hurt Memory Aripiprazole may be effective for alcohol addiction Is the New-Media Mix too Mixed? The Vytorin Letters Novartis CEO says difficult pharma business offset by 'very promising' pipeline Eisai Terminates Parkinson's Study FDA Investigates Transplant Drugs' Risks Drug Companies Will Top $1B in Direct Marketing Spend Russia Approves an Unproven Treatment Hottest U.S. Import: Digital Talent? The sudden, swift descent of a pharmaceutical empire Blood pressure drug Micardis cuts heart risk: study Doctors support universal health care: survey Scientist's Misgivings With Schering-Plough Crestor Study Halted After Strong Results Doctors Wary After Cholesterol Drug Flop Drugs to Watch
|
|
|
|
border="0"
/> |
|
|
|
|
|||||||||||